Type of publications
Regions
Countries
Diseases
Publication date

Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update of ACIP - 9 July 2021

mRNA vaccines Recommendation United States of America COVID-19
Download:
Published: 2021 Author: ACIP

ACIP Updated Recommendations for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - 27 April 2021

Janssen COVID-19 Vaccine Recommendation United States of America COVID-19
Download:
Published: 2021 Author: ACIP

ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years - May 12, 2021

Pfizer-BioNTech vaccine adolescents Recommendation United States of America COVID-19
Download:
Published: 2021 Author: ACIP

COVID-19 Vaccine Safety Technical (VaST) Subgroup

Safety Background paper United States of America COVID-19
Download:
Published: 2021 Author: Grace M Lee, ACIP

COVID-19 vaccine safety update

Safety Background paper United States of America COVID-19
Download:
Published: 2021 Author: Tom Shimabukuro, ACIP

COVID-19 Vaccine Safety Technical (VaST) Subgroup - discussion & interpretation

Safety Background paper United States of America COVID-19
Download:
Published: 2021 Author: Grace M Lee, ACIP

COVID-19 vaccine safety update - March 1st 2021

AEFI Pregnant women vaccine safety Background paper United States of America COVID-19
Download:
Published: 2021 Author: Tom Shimabukuro, ACIP

Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Janssen COVID-19 Vaccine

AEFI Janssen COVID-19 Vaccine Background paper United States of America COVID-19
Download:
Published: 2021 Author: ACIP

Epidemiology of COVID-19 in Children and Teens

Children (2-9 years) Background paper United States of America COVID-19
Download:
Published: 2021 Author: ACIP

COVID-19 Vaccines for Children

Children (2-9 years) Background paper United States of America COVID-19
Download:
Published: 2021 Author: ACIP